Alnylam Pharmaceuticals, Inc.

US BANCORP \DE\ ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/30/2026

Shares

5,236

Value ($000)

2,082

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/30/2026	2,082	0.0%	5,236	12/31/2025
2025 Q3	11/12/2025	2,575	0.0%	5,646	9/30/2025
2025 Q2	7/24/2025	1,533	0.0%	4,700	6/30/2025
2025 Q1	5/8/2025	1,239	0.0%	4,590	3/31/2025
2024 Q4	2/5/2025	1,125	0.0%	4,782	12/31/2024
2024 Q3	10/28/2024	1,534	0.0%	5,578	9/30/2024
2024 Q2	8/7/2024	1,724	0.0%	7,094	6/30/2024
2024 Q1	5/8/2024	980	0.0%	6,560	3/31/2024
2023 Q4	2/9/2024	1,388	0.0%	7,251	12/31/2023
2023 Q3	11/3/2023	1,287	0.0%	7,268	9/30/2023
2023 Q2	8/10/2023	1,409	0.0%	7,417	6/30/2023
2023 Q1	5/9/2023	1,604	0.0%	8,005	3/31/2023
2022 Q4	2/13/2023	1,909	0.0%	8,031	12/31/2022
2022 Q3	10/27/2022	1,650	0.0%	8,243	9/30/2022
2022 Q2	8/1/2022	1,174	0.0%	8,046	6/30/2022
2022 Q1	5/11/2022	1,678	0.0%	10,278	3/31/2022
2021 Q4	2/11/2022	1,628	0.0%	9,599	12/31/2021
2021 Q3	11/10/2021	1,622	0.0%	8,591	9/30/2021
2021 Q2	8/5/2021	1,437	0.0%	8,483	6/30/2021
2021 Q1	4/28/2021	1,164	0.0%	8,244	3/31/2021
2020 Q4	2/4/2021	268	0.0%	2,058	12/31/2020
2020 Q3	11/10/2020	179	0.0%	1,234	9/30/2020
2020 Q2	8/7/2020	165	0.0%	1,115	6/30/2020
2020 Q1	5/13/2020	114	0.0%	1,044	3/31/2020
2019 Q4	2/4/2020	133	0.0%	1,164	12/31/2019
2014 Q1	5/14/2014	266	0.0%	3,964	3/31/2014
2013 Q4	2/13/2014	264	0.0%	4,111	12/31/2013